JPS patients with SMAD4 mutations predominantly exhibit upper gastrointestinal polyps and hereditary hemorrhagic telangiectasia (HHT), while BMPR1A-mutated patients mainly present with colonic phenotypes [6]. Here, SMAD4 is linked to hereditary hemorrhagic telangiectasia.